BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10346068)

  • 1. Transplanting hematopoietic progenitor cells.
    Chapman B
    CAP Today; 1999 Feb; 13(2):48, 52-56, 58-9. PubMed ID: 10346068
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rich hematopoietic stem/progenitor cells in the human placenta tissue and placenta blood].
    Zhou SL; Song JQ; Xu R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):142-7. PubMed ID: 12513818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CD34+ selection and T cell immunodepletion on cord blood hematopoietic progenitors: relevance to stem cell transplantation.
    Laver J; Traycoff CM; Abdel-Mageed A; Gee A; Lee C; Turner C; Srour EF; Abboud M
    Exp Hematol; 1995 Dec; 23(14):1492-6. PubMed ID: 8542936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A contribution to a study of apoptosis of hematopoietic stem cells CD34+ by flow cytometry before and after cryopreservation].
    Ben Nasr M; Jenhani F
    Transfus Clin Biol; 2008 Jun; 15(3):91-7. PubMed ID: 18619889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct volumetric flow cytometric quantitation of CD34+ stem and progenitor cells.
    Gutensohn K; Nikolitsis A; Gramatzki M; Spitzer D; Buwitt-Beckmann U; Humpe A
    Transfus Med; 2012 Jun; 22(3):205-10. PubMed ID: 22519551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.
    Kałwak K; Porwolik J; Mielcarek M; Gorczyńska E; Owoc-Lempach J; Ussowicz M; Dyla A; Musiał J; Paździor D; Turkiewicz D; Chybicka A
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1388-401. PubMed ID: 20382248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assessment of autologous hematopoietic blood progenitor and stem cell grafting: a prospective registration study.
    Johnsen HE; Lanza F
    J Biol Regul Homeost Agents; 2002; 16(4):272-88. PubMed ID: 12597644
    [No Abstract]   [Full Text] [Related]  

  • 9. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L
    Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a single-platform method for hematopoietic CD34+ stem cells enumeration according to accreditation procedure.
    Massin F; Huili C; Decot V; Stoltz JF; Bensoussan D; Latger-Cannard V
    Biomed Mater Eng; 2015; 25(1 Suppl):27-39. PubMed ID: 25538053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control for peripheral stem cell collection: the Ottawa experience.
    Giulivi A; Huebsch LB; Van der Jagt R; Markman S; Fuller V; Birch P; Demone J; McDiermid S; Rutherford B
    Prog Clin Biol Res; 1994; 389():753-9. PubMed ID: 7535465
    [No Abstract]   [Full Text] [Related]  

  • 12. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
    Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
    Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
    Schriber JR; Dejbakhsh-Jones S; Kusnierz-Glaz CR; Ginzton N; Still B; Negrin RS; Greenberg P; Strober S
    Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period.
    Katayama Y; Mahmut N; Takimoto H; Maeda Y; Yano T; Kojima K; Azuma T; Hara M; Imajyo K; Takahashi S; Kai T; Ohno Y; Miyamoto T; Nagafuji K; Matsue K; Takenaka K; Teshima T; Shinagawa K; Ishimaru F; Omoto E; Harada M
    Bone Marrow Transplant; 1999 Apr; 23(7):659-65. PubMed ID: 10218841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression of a novel epitope of CD59 identifies a subset of CD34+ bone marrow cells highly enriched for pluripotent stem cells.
    Hill B; Rozler E; Travis M; Chen S; Zannetino A; Simmons P; Galy A; Chen B; Hoffman R
    Exp Hematol; 1996 Jul; 24(8):936-43. PubMed ID: 8690053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between graft product and donor side effects following bone marrow or stem cell donation.
    Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
    Bone Marrow Transplant; 2003 Nov; 32(9):873-80. PubMed ID: 14561987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric CD34+ determination in stem cell transplantation: before or after cryopreservation of grafts?
    Fietz T; Reufi B; Mücke C; Thiel E; Knauf WU
    J Hematother Stem Cell Res; 2002 Apr; 11(2):429-35. PubMed ID: 11983115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.